Weekend Stock Spotlight: Affirm, SoftBank And How Trump Documents Seizure May Impact Midterms
Benzinga reviews this weekend''s top stories covered by leading media outlets, here are the articles investors need to read. In Barron''s " At Last, Weight-Loss Drugs That Actually Work. They Could Be the Blockbusters of the Decade ," Bill Alpert looks at new weigh-loss medications that could become the best-selling drugs in pharmaceutical history for Novo Nordisk A|S (NYSE: NVO ) and Eli Lilly And Company (NYSE: LLY ). " The SoftBank Experiment Has Failed. Here’s What Comes Next ," by Barron''s Eric Savitz, details what''s ahead for SoftBank Group Corp (OTC: SFTBY ) after the … Full story available on Benzinga.com
Weekend Stock Spotlight: Affirm, SoftBank And How Trump Documents Seizure May Impact Midterms
Benzinga reviews this weekend''s top stories covered by leading media outlets, here are the articles investors need to read. In Barron''s " At Last, Weight-Loss Drugs That Actually Work. They Could Be the Blockbusters of the Decade ," Bill Alpert looks at new weigh-loss medications that could become the best-selling drugs in pharmaceutical history for Novo Nordisk A|S (NYSE: NVO ) and Eli Lilly And Company (NYSE: LLY ). " The SoftBank Experiment Has Failed. Here’s What Comes Next ," by Barron''s Eric Savitz, details what''s ahead for SoftBank Group Corp (OTC: SFTBY ) after the … Full story available on Benzinga.com